PT - JOURNAL ARTICLE AU - Fletez-Brant, Kipper AU - Sauteraud, Renan AU - Liang, Yanyu AU - Micheletti, Steven AU - Nandakumar, Priyanka AU - Sugathan, Aarathi AU - Song, Kijoung AU - Cavazos, Taylor B. AU - Thomas, Amal AU - Tunney, Robert J. AU - Hicks, Barry AU - O’Connell, Jared AU - Shringarpure, Suyash AU - Kukar, Katelyn AU - Moreno, Meghan AU - DelloRusso, Emily AU - Wong, Corinna D. AU - Petrakovitz, Aaron AU - Atla, Goutham AU - Cortes, Adrian AU - Gormley, Padhraig AU - Howe, Laurence AU - Mishra, Rajashree AU - Seaton, Daniel AU - the 23andMe Research Team AU - Gentleman, Robert C. AU - Pitts, Steven J. AU - Vacic, Vladimir TI - The genetic architecture of gene expression in individuals of African and European ancestry AID - 10.1101/2024.12.13.24318019 DP - 2024 Jan 01 TA - medRxiv PG - 2024.12.13.24318019 4099 - http://medrxiv.org/content/early/2024/12/16/2024.12.13.24318019.short 4100 - http://medrxiv.org/content/early/2024/12/16/2024.12.13.24318019.full AB - We conducted two large scale studies of the genetics of gene expression in individuals of African ancestry within a cohort of consented 23andMe research participants and in LCL samples from the 1000 Genomes Project African superpopulation. We discovered nearly four times as many eQTLs, compared to tissue-matched eQTL studies in European cohorts. Additionally, we found that the majority of eQTLs were not detectable across populations; those that were, however, were found to be highly concordant. Performing eQTL studies in African ancestry cohorts resulted in more signals per gene and smaller credible sets of causal variants. We showed that comparisons of heritability of gene expression could be confounded by population substructure, but that variation in local genetic ancestry did not majorly impact eQTL discovery. Finally, we showed improvements in variant-to-gene mapping of African-American GWAS signals when using African compared to European ancestry eQTL studiesCompeting Interest StatementKFB, RS, YL, SM, PN, AS, AT, RJT, BH, JOC, SS, KK, MM, EB, CW, AP, RG, SJP, VV are current or former employees of 23andMe, Inc. and may own shares of stock or stock options of 23andMe. KFB is an employee of Genentech, Inc. AS is an employee of CSL. KS, GA, AC, PG, LH, RM, DS are employees of GSK plc. TC is an employee of Exai Bio. AT is an employee of Gilead Sciences, Inc. JOC is an employee of AstraZeneca plc. AP is an employee of Genomenon, Inc.Funding StatementThis study did not receive any external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All biological sample collection was performed in accordance with the terms of informed consents and under an IRB approved protocol. Participants provided informed consent and participated in the research under a research protocol reviewed and approved by an external AAHRPP-accredited IRB, Ethical and Independent Review Services (www.eandireview.com). Participants consented to sharing of genetic and transcriptomic data via the NIH Database of Genotypes and Phenotypes (dbGaP).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesConsistent with the research consent provided, we made these datasets publicly available to all qualified researchers. RNA-seq and WGS data for Black Representation in Genomic Research is available as dbGaP study phs002969.v1.p1, and RNA-seq for the 1000 Genomes Project African superpopulation LCLs as SRA project PRJNA1108327. Upon publication the full summary statistics for the 23andMe African-American height GWAS and the BRGR eQTL study will be made available through 23andMe to qualified researchers under an agreement with 23andMe that protects the privacy of the 23andMe participants. Please visit https://research.23andme.com/collaborate/#dataset-access for more information and to apply to access the data. Upon publication genome-wide association summary statistics for the African LCL eQTL study will be freely available for download via https://www.internationalgenome.org.